Malignant News and Research

RSS

Bionanotechnology that combines the strengths of nanotechnology and biochemistry to generate a new type of bionanomaterial

A team of University of Florida researchers has created tiny hybrid particles that can speedily root out even one isolated E. coli bacterium lurking in ground beef or provide a crucial early warning alarm for bacteria used as agents of bioterrorism and for early disease diagnosis.

11 Oct 2004

University of Rochester Medical Center doctors are trying to improve childhood cancer treatments

University of Rochester Medical Center doctors are trying to improve childhood cancer treatments so that kids are less likely to develop heart problems or second malignancies later, as a result of radiation therapy.

6 Oct 2004

International symposium will focus on curing mesothelioma

A lethal, but long-overlooked cancer will take a major step out of the shadows next week, as The Mesothelioma Applied Research Foundation convenes the First International Symposium on Malignant Mesothelioma.

6 Oct 2004

In some cases, children with Hodgkin’s Disease can safely skip or reduce the amount of radiation therapy received

In some cases, children with Hodgkin’s Disease can safely skip or significantly reduce the amount of radiation therapy they must receive if the cancer has been sufficiently shrunk due to chemotherapy

5 Oct 2004

Researchers are studying a vaccine that, in the future, could be the first to treat advanced malignant melanoma

Unlike traditional vaccines, cancer vaccines are not meant to be given to healthy people to prevent cancer. Rather, they are meant to be used in sick patients to strengthen their immune system to better fight the cancer.

4 Oct 2004

New statement published on nonmalignant diseases related to asbestos exposure

In its first official statement since 1986 on the topic, the American Thoracic Society (ATS) has published a document entitled “Diagnosis and Initial Management of Nonmalignant Diseases Related to Asbestos.”

4 Oct 2004

Researchers reveal potential new role for Glivec/Imatinib

Imatinib – or Glivec as it also known – looks as if it may become an effective treatment for yet another type of cancer.

28 Sep 2004

Prostate cancer treatment leads to declines in sexual and urinary function

Treatment for prostate cancer leads to significant five-year declines in sexual and urinary function, according to a new study. However, general and other specific health-related quality of life factors, such as bowel function, are not affected.

27 Sep 2004

Dogs can be trained to detect bladder cancer

Tumours are thought to produce volatile organic compounds with distinctive odours. Even when present in minute quantities, it is possible that they are detectable by dogs, with their exceptional sense of smell.

23 Sep 2004

New link in the growth of Ewing’s sarcoma

To develop new therapeutic approaches to cancer, it is essential to understand the long and extremely complex process that underlies it, in other words the various stages of cancer development from the initial mutation to the tumor.

23 Sep 2004

Scientists have corrected a flaw in cancer cells that lets them evade the normal cell-death process

Scientists at Dana-Farber Cancer Institute have corrected a flaw in cancer cells that lets them evade the normal cell-death process, and as a result they eliminated leukemia cells from mice.

21 Sep 2004

Certain cancers might one day be cured without the use of toxic chemotherapy and radiation

The eradication of brain tumors in mice following treatment with a novel drug suggests that certain cancers might one day be cured without the use of toxic chemotherapy and radiation.

20 Sep 2004

New anti-inflammatory strategy for cancer therapy

A new strategy for cancer therapy, which converts the tumor-promoting effect of the immune system’s inflammatory response into a cancer-killing outcome, is suggested in research findings by investigators at the University of California, San Diego (UCSD) School of Medicine.

20 Sep 2004

Researchers are making inroads to understanding what makes brain tumors so hard to treat

When he's not in the operating room performing surgery, Donald M. O'Rourke, M.D., Associate Professor of Neurosurgery at the University of Pennsylvania School of Medicine is fighting brain tumors from the research laboratory bench.

16 Sep 2004

BNCT treatment has had an excellent response in a patient with head and neck cancer

A Finnish research group has been the first in the world to publish an article in which BNCT treatment has had an excellent response in a patient with head and neck cancer for whom there was no other treatment available.

14 Sep 2004

One of Australia's largest hospitals has suspected case of Creutzfeldt-Jakob Disease

The Royal Melbourne Hospital, one of Australia's largest hospitals, has contacted 1056 patients today after a man died of a suspected case of Creutzfeldt-Jakob Disease.

13 Sep 2004

Cancer survivors' other medical problems poorly managed

People who survive cancer are less likely to receive necessary care for a wide range of other non-cancer-related medical problems according to a new study published September 13, 2004 in the online edition of CANCER, a peer- reviewed journal of the American Cancer Society.

12 Sep 2004

Researchers discover that DNA fragments destroy melanoma cells

Researchers at Boston University School of Medicine have discovered that small DNA fragments or oligonucleotides that resemble the telomere (chromosome end), also called T-oligos, can cause human melanoma cells to undergo extensive apoptosis (cell death), while surviving melanoma cells become more differentiated and therefore less aggressive.

1 Sep 2004

Broccoli, cauliflower and cabbage effective in disrupting late stages of cell growth in breast cancer

A well known anti-cancer agent in certain vegetables has just had its reputation enhanced. The compound, in broccoli and other cruciferous vegetables, has been found to be effective in disrupting late stages of cell growth in breast cancer.

1 Sep 2004

Researchers accurately pinpoint the types of lymphoma, Hodgkins or non-Hodgkins

“There are many types and subtypes of lymphoma, some of which are easy to detect, but many that are very difficult to identify,” says Antonio Giordano, M.D., Ph.D., director of the Sbarro Institute at Temple and one of the study’s principal investigators.

1 Sep 2004

Malignant News and Research

Bionanotechnology that combines the strengths of nanotechnology and biochemistry to generate a new type of bionanomaterial

University of Rochester Medical Center doctors are trying to improve childhood cancer treatments

International symposium will focus on curing mesothelioma

In some cases, children with Hodgkin’s Disease can safely skip or reduce the amount of radiation therapy received

Researchers are studying a vaccine that, in the future, could be the first to treat advanced malignant melanoma

New statement published on nonmalignant diseases related to asbestos exposure

Researchers reveal potential new role for Glivec/Imatinib

Prostate cancer treatment leads to declines in sexual and urinary function

Dogs can be trained to detect bladder cancer

New link in the growth of Ewing’s sarcoma

Scientists have corrected a flaw in cancer cells that lets them evade the normal cell-death process

Certain cancers might one day be cured without the use of toxic chemotherapy and radiation

New anti-inflammatory strategy for cancer therapy

Researchers are making inroads to understanding what makes brain tumors so hard to treat

BNCT treatment has had an excellent response in a patient with head and neck cancer

One of Australia's largest hospitals has suspected case of Creutzfeldt-Jakob Disease

Cancer survivors' other medical problems poorly managed

Researchers discover that DNA fragments destroy melanoma cells

Broccoli, cauliflower and cabbage effective in disrupting late stages of cell growth in breast cancer

Researchers accurately pinpoint the types of lymphoma, Hodgkins or non-Hodgkins

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News